Overview: Isovaleric Acid TestIntroduction: The Isovaleric Acid Test measures isovaleric acid to diagnose isovaleric acidemia, causing developmental delays or metabolic crises, aiding in diagnosis and treatment. Affecting 1 in 100,000 people, isovaleric acidemia poses diagnostic challenges due to acute episodes. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses GC-MS for high accuracy, supporting biochemistry screening. This test is vital for diagnosis, treatment planning, and improving outcomes in metabolism.
Other Names: Isovaleric Acidemia Test, IVA Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Organic acid testing began in the 1960s with research by Tanaka, who identified isovaleric acid. GC-MS advancements in the 1990s by Agilent improved detection, surpassing earlier gas chromatography methods.
Purpose: Measures isovaleric acid levels to diagnose isovaleric acidemia, guides dietary or carnitine therapy, and evaluates patients with developmental delays, aiming to manage crises.
Test Parameters: Isovaleric acid levels
Pretest Condition: No special preparation required. Collect urine or plasma. Report history of metabolic issues.
Specimen: Urine (sterile container, 5-20 mL), Plasma (NaHep, 2-4 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document developmental delay or metabolic crises. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., coma), and sample collection risks.
Procedural Considerations: Uses GC-MS to measure isovaleric acid, requiring labs with gas chromatographs. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may not affect results but require correlation.
Clinical Significance: Elevated levels confirm isovaleric acidemia, guiding therapy. Early treatment might prevent crises, while untreated cases lead to death. Normal levels may require genetic tests.
Specialist Consultation: Consult a metabolic specialist for interpretation.
Additional Supporting Tests: Urine organic acids, ammonia levels, or genetic panel to confirm diagnosis.
Test Limitations: Specific to isovaleric acid; correlation with symptoms needed. False negatives possible with low levels.
References: ACMG Guidelines, 2023; Journal of Pediatrics, Tanaka K, 2022.
